Skip to main content
Clinical Trials/NCT04292171
NCT04292171
Completed
Early Phase 1

Gabapentin for Perioperative Pain Relief in Surgical Abortion: a Double-blind Randomized Controlled Trial

University of Nevada, Las Vegas1 site in 1 country219 target enrollmentMay 1, 2017

Overview

Phase
Early Phase 1
Intervention
Gabapentin
Conditions
Pain Control
Sponsor
University of Nevada, Las Vegas
Enrollment
219
Locations
1
Primary Endpoint
Pain Score
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

Gabapentin preoperative use for evaluation of benefit to reduce pain during and after surgical office-based abortion.

Detailed Description

A double-blind placebo controlled trial of gabapentin in the setting of an ambulatory surgical abortion center where patients receive either the routine intravenous sedation, local cervical anesthesia plus 600mg of gabapentin one hour prior to surgery vs. the same regimen plus placebo one hour prior to surgery. Our primary outcome measure will be post-operative validated pain scores using a 11-point visual analog scale (VAS). Secondary measures will include nausea and vomiting during, after and 24 hours after the procedure. A second and third pain assessment using VAS will be made at 30 minutes and at 24 hours postoperatively.

Registry
clinicaltrials.gov
Start Date
May 1, 2017
End Date
March 30, 2018
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Adam Levy

Associate Professor, OB/GYN

University of Nevada, Las Vegas

Eligibility Criteria

Inclusion Criteria

  • Women seeking surgical abortion between 5 and 23 6/7 weeks of ultrasound age.
  • English or Spanish speaking
  • eligible for office-based surgical pregnancy termination

Exclusion Criteria

  • present use of gabapentin or pregabalin,
  • renal disease
  • sensitivity or allergy to gabapentin
  • Missed abortion

Arms & Interventions

Gabapentin Arm

Gabapentin 600 mg given 1-2 hours prior to surgical abortion

Intervention: Gabapentin

Placebo Arm

Placebo (vit C) given 1-2 hours prior to surgical abortion

Intervention: Placebos

Outcomes

Primary Outcomes

Pain Score

Time Frame: 5 minutes postoperative

100mm Visual analog scale (VAS) for level of pain, 1-100, 1=no pain, 100= extreme pain

Secondary Outcomes

  • Nausea(24 hours postoperative)
  • Pain Score 24(24 hours postop)
  • Vomiting(24 hours postoperative)
  • Pain Score at 30 Minutes Postoperative(30 minutes postoperative)

Study Sites (1)

Loading locations...

Similar Trials